Literature DB >> 26807418

Charged particles for liver cancer.

Marco Durante1.   

Abstract

Entities:  

Year:  2015        PMID： 26807418      PMCID： PMC4701523          DOI： 10.3978/j.issn.2305-5839.2015.12.32

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  13 in total

1.  Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma.

Authors:  Shohei Komatsu; Takumi Fukumoto; Yusuke Demizu; Daisuke Miyawaki; Kazuki Terashima; Ryohei Sasaki; Yuichi Hori; Yoshio Hishikawa; Yonson Ku; Masao Murakami
Journal:  Cancer       Date:  2011-04-14       Impact factor: 6.860

Review 2.  Is there a role for proton therapy in the treatment of hepatocellular carcinoma? A systematic review.

Authors:  Francesco Dionisi; Lamberto Widesott; Stefano Lorentini; Maurizio Amichetti
Journal:  Radiother Oncol       Date:  2014-02-20       Impact factor: 6.280

Review 3.  Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience.

Authors:  Tadashi Kamada; Hirohiko Tsujii; Eleanor A Blakely; Jürgen Debus; Wilfried De Neve; Marco Durante; Oliver Jäkel; Ramona Mayer; Roberto Orecchia; Richard Pötter; Stanislav Vatnitsky; William T Chu
Journal:  Lancet Oncol       Date:  2015-02       Impact factor: 41.316

4.  Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis.

Authors:  Hiroshi Imada; Hirotoshi Kato; Shigeo Yasuda; Shigeru Yamada; Takeshi Yanagi; Riwa Kishimoto; Susumu Kandatsu; Jun-etsu Mizoe; Tadashi Kamada; Osamu Yokosuka; Hirohiko Tsujii
Journal:  Radiother Oncol       Date:  2010-06-25       Impact factor: 6.280

Review 5.  Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma.

Authors:  Mary Maluccio; Anne Covey
Journal:  CA Cancer J Clin       Date:  2012-10-15       Impact factor: 508.702

Review 6.  Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.

Authors:  Jonathan Klein; Laura A Dawson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-12-06       Impact factor: 7.038

Review 7.  Charged particle therapy--optimization, challenges and future directions.

Authors:  Jay S Loeffler; Marco Durante
Journal:  Nat Rev Clin Oncol       Date:  2013-05-21       Impact factor: 66.675

8.  Four-dimensional patient dose reconstruction for scanned ion beam therapy of moving liver tumors.

Authors:  Daniel Richter; Nami Saito; Naved Chaudhri; Martin Härtig; Malte Ellerbrock; Oliver Jäkel; Stephanie E Combs; Daniel Habermehl; Klaus Herfarth; Marco Durante; Christoph Bert
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-01       Impact factor: 7.038

Review 9.  Role of stereotactic body radiation therapy for hepatocellular carcinoma.

Authors:  Naoko Sanuki; Atsuya Takeda; Etsuo Kunieda
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

10.  Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - feasibility and clinical response.

Authors:  Daniel Habermehl; Jürgen Debus; Tom Ganten; Maria-Katharina Ganten; Julia Bauer; Ingo C Brecht; Stephan Brons; Thomas Haberer; Martin Haertig; Oliver Jäkel; Katia Parodi; Thomas Welzel; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2013-03-13       Impact factor: 3.481
View more
  1 in total

1.  Assessing the uncertainty in a normal tissue complication probability difference (∆NTCP): radiation-induced liver disease (RILD) in liver tumour patients treated with proton vs X-ray therapy.

Authors:  Keiji Kobashi; Anussara Prayongrat; Takuya Kimoto; Chie Toramatsu; Yasuhiro Dekura; Norio Katoh; Shinichi Shimizu; Yoichi M Ito; Hiroki Shirato
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.